全文获取类型
收费全文 | 146篇 |
免费 | 7篇 |
国内免费 | 7篇 |
专业分类
儿科学 | 13篇 |
妇产科学 | 3篇 |
基础医学 | 18篇 |
口腔科学 | 4篇 |
临床医学 | 16篇 |
内科学 | 19篇 |
神经病学 | 55篇 |
特种医学 | 6篇 |
外科学 | 5篇 |
综合类 | 3篇 |
预防医学 | 4篇 |
眼科学 | 4篇 |
药学 | 9篇 |
肿瘤学 | 1篇 |
出版年
2021年 | 1篇 |
2020年 | 1篇 |
2019年 | 1篇 |
2018年 | 5篇 |
2017年 | 3篇 |
2016年 | 9篇 |
2015年 | 7篇 |
2014年 | 6篇 |
2013年 | 23篇 |
2012年 | 8篇 |
2011年 | 4篇 |
2010年 | 11篇 |
2009年 | 9篇 |
2008年 | 15篇 |
2007年 | 10篇 |
2006年 | 2篇 |
2005年 | 5篇 |
2004年 | 4篇 |
2003年 | 1篇 |
2002年 | 1篇 |
2001年 | 1篇 |
1999年 | 1篇 |
1998年 | 6篇 |
1997年 | 3篇 |
1996年 | 2篇 |
1995年 | 3篇 |
1994年 | 1篇 |
1993年 | 3篇 |
1992年 | 1篇 |
1989年 | 2篇 |
1988年 | 4篇 |
1986年 | 2篇 |
1983年 | 1篇 |
1980年 | 1篇 |
1965年 | 1篇 |
1959年 | 1篇 |
1951年 | 1篇 |
排序方式: 共有160条查询结果,搜索用时 0 毫秒
1.
van Leth F Huisamen CB Badaro R Vandercam B de Wet J Montaner JS Hall DB Wit FW Lange JM;NN Study Group 《Journal of acquired immune deficiency syndromes (1999)》2005,38(3):296-300
BACKGROUND: The initial rate of plasma HIV-1 RNA (pVL) decline has been proposed as a marker of early efficacy of antiretroviral therapy (ART) and a possible predictor of late efficacy. We compared the rate of pVL decline in patients starting ART with nevirapine (NVP), efavirenz (EFV), or both drugs combined in addition to lamivudine (3TC) and stavudine (d4T). METHODS: Analysis of the viral decay constant (VDc) during the first 2 weeks of treatment in patients enrolled in the 2NN study who remained on allocated treatment. RESULTS: The median VDc (log10 copies per day, [interquartile range]) was similar for NVP (0.30 [0.25-0.36], EFV (0.31 [0.27-0.37]), and NVP + EFV (0.30 [0.27-0.36]). Patients with a baseline pVL >100,000 copies/mL were 8.7 (95% confidence interval [CI]: 6.2-12.3) times more likely to have a VDc >75th percentile. A high VDc was not associated with plasma drug concentration or with a decreased risk of virologic failure at week 48 after the start of therapy (hazard ratio = 0.8, 95% CI: 0.6-1.2). CONCLUSION: NVP, EFV, or NVP + EFV in combination with 3TC and d4T show similar rates of pVL decline during the first 2 weeks of treatment. The VDc with these regimens is not predictive of late virologic efficacy. 相似文献
2.
3.
4.
Neurocognitive predictors of substance use disorders and nicotine dependence in ADHD probands,their unaffected siblings,and controls: a 4‐year prospective follow‐up 下载免费PDF全文
5.
6.
Francesca Waddington Catharina Hartman Yvette de Bruijn Martijn Lappenschaar Anoek Oerlemans Jan Buitelaar Barbara Franke Nanda Rommelse 《European neuropsychopharmacology》2018,28(9):994-1005
Autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) are frequently comorbid disorders. Emotion recognition problems are considered an important familial deficit in ASD, but this is unknown in ADHD. Very few studies have directly compared emotion recognition performance of youth with ASD and/or ADHD and of their unaffected siblings across age to quantify the contribution of emotion recognition problems to the ADHD phenotype. We therefore devised a study of 64 ASD+ADHD participants, 89 ASD-only participants, 111 ADHD-only participants, 122 unaffected ASD(+ADHD) siblings, 69 unaffected ADHD-only siblings and 220 controls aged 7–18 years, who had completed two tasks assessing auditory and visual emotion recognition. Factor analysis was used to detect underlying dimensions of emotion recognition capacity. Linear mixed models were used to compare performance across groups and to assess age effects. The factor-analysis revealed four factors separating speed and accuracy regarding visual and auditory emotion recognition. ASD+ADHD, ASD-only, and ADHD-only participants all performed worse than controls. ASD+ADHD, ASD-only, and ADHD-only participants did not differ in the severity of their emotion recognition problems. Both unaffected sibling groups performed intermediate between patients and controls. For ASD+ADHD and ADHD-only participants, group differences were more marked in adolescence than childhood, whereas in ASD participants this was not observed. We conclude that emotion recognition problems are a familial deficit in ADHD to a similar extent as in ASD. Emotion recognition problems specifically - and social cognition problems more generally - should be assessed in clinical practice for ADHD. 相似文献
7.
Karin T. Beuker Synnve Schjølberg Kari Kveim Lie Sophie Swinkels Nanda N. J. Rommelse Jan K. Buitelaar 《European child & adolescent psychiatry》2014,23(11):1081-1091
The Modified Checklist for Autism in Toddlers (M-CHAT) and the Early Screening of Autistic Traits (ESAT) were designed to screen for autism spectrum disorders in very young children. The aim of this study was to explore proportions of children that screened positive on the ESAT or the M-CHAT and to investigate if screening positive on the ESAT and M-CHAT is associated with clinical referral by 18 months and other aspects of children’s development, health, and behavior. In this study, the mothers of 12,948 18-month-old children returned a questionnaire consisting of items from the ESAT and M-CHAT, plus questions about clinical and developmental characteristics. The M-CHAT identified more screen-positive children than the ESAT, but the ESAT was associated with more clinical referrals and tended to identify more children with medical, language, and behavioral problems. A post hoc analysis of combining the two instruments found this to be more effective than the individual instruments alone in identifying children referred to clinical services at 18 months. Further analysis at the level of single items is warranted to improve these screening instruments. 相似文献
8.
Margo Schrieken Janne Visser Iris Oosterling Daphne van Steijn Daniëlle Bons Jos Draaisma Rutger-Jan van der Gaag Jan Buitelaar Rogier Donders Nanda Rommelse 《European child & adolescent psychiatry》2013,22(1):35-43
Pre/perinatal risk factors and body growth abnormalities have been studied frequently as early risk markers in autism spectrum disorder (ASD), yet their interrelatedness in ASD has received very little research attention. This is surprising, given that pre/perinatal risk factors can have a substantial impact on growth trajectories in the first years of life. We aimed to determine which pre/perinatal factors were more prevalent in ASD children and if these factors differentially influenced body growth in ASD and control children. A total of 96 ASD and 163 control children matched for gender participated. Data of growth of head size and body length during the first 13 months of life were collected. Data on pre/perinatal risk factors were retrospectively collected through standardized questionnaires. Results indicated that after matching for SES, prematurity/low birth weight and being first born were more prevalent in the ASD versus the control group. In addition, with increasing age children with ASD tended to have a proportionally smaller head circumference compared to their height. However, the effect of prematurity/low birth weight on head growth corrected for height was significantly different in ASD and control children: premature/low birth weight control children showed a disproportionate larger head circumference in relation to height during their first year of life, whereas this effect was absent in premature/low birth weight ASD children. This may suggest that the etiology of abnormal growth is potentially different in ASD and control children: where abnormal growth in control children is related to suboptimal conditions in the uterus, abnormal growth in ASD may be more strongly related to the causal factors that also increase the risk for ASD. However, prospective studies measuring growth and ASD characteristics in both premature/low birth weight and a terme children are necessary to support this conclusion. 相似文献
9.
Judith S. Nijmeijer Alejandro Arias-Vásquez Nanda N.J. Rommelse Marieke E. Altink Richard J.L. Anney Philip Asherson Tobias Banaschewski Cathelijne J.M. Buschgens Ellen A. Fliers Michael Gill Ruud B. Minderaa Luise Poustka Joseph A. Sergeant Jan K. Buitelaar Barbara Franke Richard P. Ebstein Ana Miranda Fernando Mulas Robert D. Oades Herbert Roeyers Pieter J. Hoekstra 《Journal of the American Academy of Child and Adolescent Psychiatry》2010,49(7):675-685
10.